Skip to content
value.today

ABK Biomedical Inc

Total raised
$99 M
5 rounds on record
Latest round
$3 M
Oct 2025
First round on record
Apr 2019
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ABK Biomedical Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2025$3 MNo. 5$2 to $10 million

ABK Biomedical Inc: Raise no. 5, Oct 2025

Investors in this round

6 investors had bought by the notice of Nov 3, 2025: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nova Scotia, Canada

People named in the notice

  • Anthony Headley · Executive Officer
  • Aravind Arepally · Executive Officer
  • David Dobrowsky · Executive Officer
  • Gary Donofrio · Executive Officer
  • Lucy Bellardine Bataneant · Executive Officer
  • Marc Gregoire · Executive Officer
  • Michael Mangano · Executive Officer, Director
  • Mike Tyson · Executive Officer
  • Aaron Berez · Director
  • Carissa Bellardine Black · Director
  • James Bellardine Eadie · Director
  • James Bellardine McLaren · Director
  • Joseph Bellardine Siletto · Director
  • Keten Patel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”

Signed by Michael Mangano, President and CEO. Source: SEC Form D, newest notice filed Nov 3, 2025. Read the notice at the SEC.

equitySEC
Apr 2025$26 MNo. 4$10 to $50 million

ABK Biomedical Inc: Raise no. 4, Apr 2025

Investors in this round

24 investors had bought by the notice of May 13, 2025: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $26 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nova Scotia, Canada

People named in the notice

  • Anthony Headley · Executive Officer
  • Aravind Arepally · Executive Officer
  • David Dobrowsky · Executive Officer
  • Gary Donofrio · Executive Officer
  • Lucy Bellardine Bataneant · Executive Officer
  • Marc Gregoire · Executive Officer
  • Michael Mangano · Executive Officer, Director
  • Mike Tyson · Executive Officer
  • Aaron Berez · Director
  • Carissa Bellardine Black · Director
  • James Bellardine Eadie · Director
  • James Bellardine McLaren · Director
  • Joseph Bellardine Siletto · Director
  • Keten Patel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”

Signed by Michael Mangano, President and CEO. Source: SEC Form D, newest notice filed May 13, 2025. Read the notice at the SEC.

equitySEC
Dec 2022$29 MNo. 3$10 to $50 million

ABK Biomedical Inc: Raise no. 3, Dec 2022

Investors in this round

23 investors had bought by the notice of Dec 22, 2022: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $29 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nova Scotia, Canada

People named in the notice

  • Anthony Headley · Executive Officer
  • Aravind Arepally · Executive Officer
  • David Dobrowski · Executive Officer
  • Gary Donofrio · Executive Officer
  • Marc Gregoire · Executive Officer
  • Michael Mangano · Executive Officer, Director
  • Mike Tyson · Executive Officer
  • Aaron Berez · Director
  • Carissa Black · Director
  • James McLaren · Director
  • Ketan Patel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”

Signed by Michael Mangano, President and CEO. Source: SEC Form D, newest notice filed Dec 22, 2022. Read the notice at the SEC.

equitySEC
Sep 2022$18 MNo. 2$10 to $50 million

ABK Biomedical Inc: Raise no. 2, Sep 2022

Investors in this round

16 investors had bought by the notice of Sep 23, 2022: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $18 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nova Scotia, Canada

People named in the notice

  • Anthony Headley · Executive Officer
  • Aravind Arepally · Executive Officer
  • David Dobrowsky · Executive Officer
  • Gary Donofrio · Executive Officer
  • Marc Gregoire · Executive Officer
  • Michael Mangano · Executive Officer, Director
  • Mike Tyson · Executive Officer
  • Aaron Berez · Director
  • James McLaren · Director
  • Ketan Patel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”

Signed by Michael Mangano, President and CEO. Source: SEC Form D, newest notice filed Sep 23, 2022. Read the notice at the SEC.

equitySEC
Apr 2019$24 MNo. 1$10 to $50 million

ABK Biomedical Inc: Raise no. 1, Apr 2019

Investors in this round

10 investors had bought by the notice of Apr 22, 2019: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nova Scotia, Canada

People named in the notice

  • Bob Abraham · Executive Officer, Director
  • David Dobrowski · Executive Officer
  • Gary Donofrio · Executive Officer
  • Marc Gregoire · Executive Officer
  • Michael Mangano · Executive Officer, Director
  • Michael Tyson · Executive Officer
  • Aaron Berez · Director
  • James McLaren · Director
  • Robert Orr · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Mangano, Chief Executive Officer and President. Source: SEC Form D, newest notice filed Apr 22, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ABK Biomedical Inc chose not to state its revenue in its newest notice of a funding round (Nov 2025).

    SEC Form D · Nov 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2025

That is all the official record says: ABK Biomedical Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of ABK Biomedical Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 24 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ABK Biomedical Inc
NameRoleNamed in
Anthony HeadleyExecutive officerNov 2025
Aravind ArepallyExecutive officerNov 2025
David DobrowskyExecutive officerNov 2025
Gary DonofrioExecutive officerNov 2025
Lucy Bellardine BataneantExecutive officerNov 2025
Marc GregoireExecutive officerNov 2025
Michael ManganoExecutive officerNov 2025
Mike TysonExecutive officerNov 2025
David DobrowskiExecutive officerDec 2022
Bob AbrahamExecutive officerApr 2019
Michael TysonExecutive officerApr 2019
Aaron BerezDirectorNov 2025
Carissa Bellardine BlackDirectorNov 2025
James Bellardine EadieDirectorNov 2025
James Bellardine McLarenDirectorNov 2025
Joseph Bellardine SilettoDirectorNov 2025
Keten PatelDirectorNov 2025
Michael ManganoDirectorNov 2025
Carissa BlackDirectorDec 2022
James McLarenDirectorDec 2022
Ketan PatelDirectorDec 2022
Bob AbrahamDirectorApr 2019
Robert OrrDirectorApr 2019